VincentiF., AmendW.J., AbeleJ., FeduskaN.J., SalvatierraO.The role of hypertension in hemodialysis associated atherosclerosis.Am J Med1980; 68: 363–9.
4.
NichollsA.J., CattoG.R.D., EdwardN., EngesetJ., MacleodM.Accelerated atherosclerosis in long term hemodialysis and renal transplant patients: fact or fiction?Lancet1980; 1; 276–8.
RostandS.G., GretesJ.C., KirkK.A., RutskyE.A., AndreoliT.E.Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis.Kidney Int1979; 16: 600–11.
7.
BroyerM., BrunnerF.P., BryngerH.Combined report on regular dialysis and transplantation in Europe.Report Eur Dial Transplant Assoc XII, Madrid1982; 19: 260.
8.
FrankW.M., RaoT.K.S., ManisT.Relationship of plasma lipids to renal function and length of time on maintenance hemodialysis.Am J Clin Nutr1978; 31: 1886–92.
9.
RosenmanR.H., BrandR.J., JenkinsC.D.Coronary heart disease in the Western Group study.JAMA1975; 233: 872–7.
10.
RossR.The pathogenesis of atherosclerosis - an update.N Engl J Med1986; 314: 488–500.
ReidyM.A., SchwartzS.M.Recent advances in molecular pathology: arterial endothelium-assessment of in vivo injury.Exp Mol Pathol1984; 41: 419–34.
16.
ReidyM.A., SchwartzS.M.Endothelial injury and regeneration. III. Time course of intimal changes after small defined injury to rat aortic endothelium.Lab Invest1983; 48: 25–34.
17.
GordonT., CastelliW.P., HjortlandM.C.Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham Study.Ann Intern Med1977; 87: 393.
18.
GordonT., CastelliW.P., HjortlandM.C.High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.Am J Med1979; 62: 707–14.
19.
BlanckenhornD.H., BrooksS.H., SelzerR.H., BarndtR.The rate of atherosclerosis change during treatment of hyperlipoproteinemia.Circulation1978; 57: 355–61.
20.
DaytonS., PearceM.L., HashimotoS., DixonW.J., To-miyasuU.A controlled clinical trial of a diet high in unsaturated fat.Circulation1969; 39-40 (suppl II): 1–63.
21.
RiesenW.F., MordasiniR.Hyperlipidemia in renal failure: phenotypes and pathogenic mechanisms.Contrib Nephrol1984; 41; 312–20.
22.
IblesL.S., SimonsL.A., KingJ.O., WilliamsP.F., NealeF.C., StewartJ.H.Studies on the nature and causes of hyperlipidemia in uremia, maintenance dialysis and renal transplantation.Q J Med1975; 44: 601–14.
23.
HahnR., OetteK., MondorfH., FinkeK., SeiberthH.G.Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias.Atherosclerosis1983; 48: 279–88.
24.
GrutzmacherP., MarzW., PeschkeB., GrossW., SchoeppeW.Lipoproteins and apolipoproteins during the progression of chronic renal disease.Nephron1988; 50: 103–11.
25.
AttmanP-O, AlaupovicP., Knight-GibsonC., TavellaM.The compositional abnormalities in lipoprotein density classes of patients with chronic renal failure.Am J Kidney Dis1989; 14: 432 (abstract).
26.
PonticelliC., BarbeG., CataluppiA., DonatiC., AnnoniG., BrancacciD.Lipid abnormalities in maintenance dialysis patients and renal transplant recipients.Kidney Int1978; 13: 572–8.
27.
AvramM.M., FeinP.A., AnignaniA.Cholesterol and lipid disturbances in renal disease: the natural history of uremic dyslipidemia and the impact of hemodialysis and CAPD.Am J Med1989; 87: (5N) 55–61N.
28.
PapadopoulusN.M., BordrW.Z., ElinR.J., DiamondL.H.An abnormal lipoprotein in the serum of uremic patients maintained on chronic hemodialysis.Ann Intern Med1980; 92: 634–5.
AttmanP-O, AlaupovicP.Lipid and apolipoprotein profiles of uremic dyslipoproteinemia. The relation to renal function and dialysis.Nephron1991; 57: 401–10.
35.
WakabayashiY., OkuboM., ShimadeH.Decreased VLDL apoprotein C-II/apoprotein C-III ratio may be seen in both normotriglyceridemic and hypertriglyceri-demic patients on chronic hemodialysis treatment.Metabolism1987; 36: 815–20.
36.
CamejoG., RieraG., LeeM., LopezF.Lipoprotein structural abnormalities in chronic renal failure with and without hemodialysis.Biomed Biochim Acta1988; 4: 239–45.
37.
GoldbergA.P., SherrardD.J., BrunzellJ.D.Adipose tissue lipoprotein lipase in chronic hemodialysis: role in plasma triglyceride metabolism.J Clin Endocrinol Metab1978; 47: 1173–82.
38.
DemantT., CarlsonL.A., HolmquistL.Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein.J Lipid Res1988; 29: 1603–11.
39.
RoulletJ-B, LacourB., YvertJ-P, PratJ-J, DruekeT.Factors of increase in serum triglyceride rich lipoproteins in uremic rats.Kidney Int1985; 27: 420–5.
40.
RoulletJ-B, LacourB., YvertJ-P, DruekeT.Correction by insulin of disturbed TG-rich LP metabolism in rats with chronic renal failure.Am J Physiol1986; 250: E373–6.
41.
HuttunenJ.K., PasternackA., VanttinenT., EhnholmC., NikkilaE.A.Lipoprotein metabolism in patients with chronic uremia.Acta Med Scand1978; 204: 211–8.
42.
ErkelensD.W., MockingJ.A.J.The C-II/C-III ratio of transferable apolipoprotein in primary and secondary hypertriglyceridemia.Clin Chim Acta1982; 121: 59–65.
43.
AtgarV., BeyneP., FrommherzK., RoulletJ.B., DruekeT.Presence of apoB-48, and relative apoC-II deficiency and apoC-III enrichment in uremic very-low density lipoproteins.Ann Biol Clin1989; 47: 497–501.
44.
MuraseT., CattranD.C., RubensteinB., SteinerG.Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia.Metabolism1975; 24: 1279–86.
45.
CrawfordG.A., MahonyJ.F., StewartJ.H.Impaired lipoprotein lipase activation by uremic and post-transplant sera.Clin Sci1981; 60: 73–80.
McLeodR., ReeveC.E., FrohlichJ.Plasma lipoproteins and lecithin: cholesterol acyltransferase distribution in patients on dialysis.Kidney Int1984; 25: 683–8.
